Ching‐Feng Chiu

1.6k total citations
59 papers, 1.3k citations indexed

About

Ching‐Feng Chiu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ching‐Feng Chiu has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Ching‐Feng Chiu's work include MicroRNA in disease regulation (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and RNA modifications and cancer (8 papers). Ching‐Feng Chiu is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and RNA modifications and cancer (8 papers). Ching‐Feng Chiu collaborates with scholars based in Taiwan, United States and Thailand. Ching‐Feng Chiu's co-authors include Hari H. Dayal, Donn Muhleman, Raoul J. Burchette, Linda Hyder Ferry, Shu‐Mei Liang, Ting‐Fang Wang, Sun Hanying, Chih‐Hsiang Leng, Yen‐Hao Su and Su‐Ming Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ching‐Feng Chiu

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Feng Chiu Taiwan 19 674 328 313 145 117 59 1.3k
Marta Moretti Italy 17 849 1.3× 236 0.7× 324 1.0× 120 0.8× 148 1.3× 37 1.4k
Damali N. Martin United States 12 408 0.6× 242 0.7× 192 0.6× 106 0.7× 211 1.8× 21 1.0k
Sergio L. Colombo United Kingdom 16 807 1.2× 161 0.5× 297 0.9× 235 1.6× 130 1.1× 28 1.6k
Fei Ding China 22 581 0.9× 353 1.1× 155 0.5× 130 0.9× 100 0.9× 82 1.3k
Yao Zhou China 19 701 1.0× 147 0.4× 318 1.0× 100 0.7× 215 1.8× 55 1.3k
Sun Young Moon South Korea 19 1.1k 1.6× 198 0.6× 109 0.3× 97 0.7× 63 0.5× 51 1.8k
Ming Lu China 19 1.0k 1.5× 263 0.8× 482 1.5× 83 0.6× 287 2.5× 62 1.8k
Altaf H. Sarker United States 23 1.5k 2.2× 210 0.6× 229 0.7× 197 1.4× 61 0.5× 42 1.8k
Zhijun Liu China 19 518 0.8× 145 0.4× 236 0.8× 92 0.6× 123 1.1× 74 1.3k

Countries citing papers authored by Ching‐Feng Chiu

Since Specialization
Citations

This map shows the geographic impact of Ching‐Feng Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Feng Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Feng Chiu more than expected).

Fields of papers citing papers by Ching‐Feng Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Feng Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Feng Chiu. The network helps show where Ching‐Feng Chiu may publish in the future.

Co-authorship network of co-authors of Ching‐Feng Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Feng Chiu. A scholar is included among the top collaborators of Ching‐Feng Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Feng Chiu. Ching‐Feng Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wanyu, Hsin‐An Chen, Chih-Ming Su, et al.. (2025). FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma. Cancer & Metabolism. 13(1). 7–7. 1 indexed citations
2.
Chiu, Ching‐Feng, Jonathan Jaime G. Guerrero, Jiayan Zhou, et al.. (2024). Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. Cancers. 16(20). 3513–3513. 7 indexed citations
3.
Chiu, Ching‐Feng, et al.. (2024). Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma. Translational Gastroenterology and Hepatology. 9. 36–36. 3 indexed citations
4.
Kamkaew, Anyanee, et al.. (2023). Hyperglycemia AltersO-GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen. In Vivo. 37(2). 685–695. 4 indexed citations
5.
Chiu, Ching‐Feng. (2023). Abstract 378: Ferritin regulates oxaliplatin sensitivity and immunosuppression in pancreatic ductal adenocarcinoma. Cancer Research. 83(7_Supplement). 378–378. 1 indexed citations
6.
Hung, Shao‐Wen, et al.. (2023). A Mitochondrion-Targeting Protein (B2) Primes ROS/Nrf2-Mediated Stress Signals, Triggering Apoptosis and Necroptosis in Lung Cancer. Biomedicines. 11(1). 186–186. 3 indexed citations
7.
8.
Yeh, Yu‐Wen, Yen‐Hao Su, Chih‐Hsin Wang, et al.. (2023). Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression. Aging. 15(22). 12873–12889.
9.
Park, Ji Min, Jei‐Ming Peng, Yen‐Hao Su, et al.. (2022). Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer. Molecular Metabolism. 65. 101576–101576. 7 indexed citations
10.
Huang, Shih‐Yi, et al.. (2022). Aspartame consumption during pregnancy impairs placenta growth in mice through sweet taste receptor-reactive oxygen species-dependent pathway. The Journal of Nutritional Biochemistry. 113. 109228–109228. 13 indexed citations
11.
Peng, Jei‐Ming, Ching‐Feng Chiu, Jai‐Hong Cheng, et al.. (2022). Evasion of NK cell immune surveillance via the vimentin-mediated cytoskeleton remodeling. Frontiers in Immunology. 13. 883178–883178. 7 indexed citations
12.
Chiu, Ching‐Feng, et al.. (2020). The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer. Biomedicine & Pharmacotherapy. 128. 110309–110309. 19 indexed citations
13.
Chiu, Chien-Chao, Shao-Wen Hung, Wen-Ching Huang, et al.. (2019). The germ-free mice monocolonization with Bacteroides fragilis improves azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer. Immunopharmacology and Immunotoxicology. 41(2). 207–213. 13 indexed citations
14.
Chang, Yi-Wen, Ching‐Feng Chiu, Kang-Yun Lee, et al.. (2015). CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis. American Journal of Respiratory and Critical Care Medicine. 192(1). 64–75. 29 indexed citations
15.
Hong, Chih-Chen, Pai‐Sheng Chen, Jean Chiou, et al.. (2014). miR326 Maturation Is Crucial for VEGF-C–Driven Cortactin Expression and Esophageal Cancer Progression. Cancer Research. 74(21). 6280–6290. 29 indexed citations
16.
Su, Yen‐Hao, et al.. (2014). Suppression of Dicer Increases Sensitivity to Gefitinib in Human Lung Cancer Cells. Annals of Surgical Oncology. 21(S4). 555–563. 24 indexed citations
17.
18.
Peng, Jei‐Ming, Yee‐Hsiung Chen, Shao‐Wen Hung, et al.. (2011). Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down‐regulate Akt and MMP‐2. British Journal of Pharmacology. 165(2). 479–493. 20 indexed citations
19.
Hanying, Sun, Su‐Ming Hu, Ching‐Feng Chiu, et al.. (2008). An improved SUMO fusion protein system for effective production of native proteins. Protein Science. 17(7). 1241–1248. 103 indexed citations
20.
Ferry, Linda Hyder, et al.. (1996). The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics. 6(1). 73–79. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Moretti Breakdown of academic impact, for papers by Damali N. Martin Breakdown of academic impact, for papers by Sergio L. Colombo Breakdown of academic impact, for papers by Fei Ding Breakdown of academic impact, for papers by Yao Zhou Breakdown of academic impact, for papers by Sun Young Moon Breakdown of academic impact, for papers by Ming Lu Breakdown of academic impact, for papers by Altaf H. Sarker Breakdown of academic impact, for papers by Zhijun Liu
Rankless by CCL
2026